MENICALI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 162
EU - Europa 142
AS - Asia 47
Totale 351
Nazione #
US - Stati Uniti d'America 162
IT - Italia 54
IE - Irlanda 28
SE - Svezia 20
VN - Vietnam 16
HK - Hong Kong 12
SG - Singapore 10
FR - Francia 8
RU - Federazione Russa 8
UA - Ucraina 8
CN - Cina 7
FI - Finlandia 5
BE - Belgio 2
CH - Svizzera 2
DE - Germania 2
GB - Regno Unito 2
AT - Austria 1
CZ - Repubblica Ceca 1
GR - Grecia 1
KR - Corea 1
TR - Turchia 1
Totale 351
Città #
Chandler 55
Perugia 30
Dublin 28
Dong Ket 16
San Mateo 13
Hong Kong 12
Altamura 10
Ann Arbor 10
Lawrence 7
Medford 7
Princeton 7
Singapore 7
Andover 6
Wilmington 5
Jacksonville 4
Terni 4
Des Moines 3
Brussels 2
Ivrea 2
Redmond 2
Saint Petersburg 2
Woodbridge 2
Beijing 1
Boardman 1
Chicago 1
Helsinki 1
Izmir 1
Jesi 1
Los Angeles 1
Mountain View 1
Nanchang 1
Ravenna 1
Seoul 1
Totale 245
Nome #
Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation 82
Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-Like 60
The aryl hydrocarbon receptor is expressed in thyroid carcinoma and appears to mediate epithelial-mesenchymal-transition 54
INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) IS UPREGULATED IN THYROID CARCINOMA AND DRIVES THE DEVELOPMENT OF AN IMMUNOSUPPRESSANT TUMOR MICROENVIRONMENT. 49
Signal transducer and activator of transcription 1 plays a pivotal role in RET/PTC3 oncogene-induced expression of indoleamine 2,3-dioxygenase 1 42
Intracellular Signal Transduction and Modification of the Tumor Microenvironment Induced by RET/PTCs in Papillary Thyroid Carcinoma 41
THERAPY of ENDOCRINE DISEASE Immunotherapy of advanced thyroid cancer: From bench to bedside 32
Immune Landscape of Thyroid Cancers: New Insights 8
Totale 368
Categoria #
all - tutte 1.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.495


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017 2 1 1 1 2 0 2 4 3 1 0 0
2020/202155 1 1 3 2 11 4 2 0 7 4 3 17
2021/202283 2 10 0 7 1 0 1 19 1 19 14 9
2022/2023132 8 29 1 15 18 11 0 7 40 1 2 0
2023/202443 4 8 1 0 0 0 10 2 2 1 9 6
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 368